Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
N-(5-chloro-benzo[b]thiophen-3-ylmethyl)-2-[6-chloro-oxo-3-(2-pyridin-2-yl-ethylamino)-2H-pyrazin-1-yl]-acetamide
- Development stage
- Unknown
- Modality
- Small Molecules
01
Overview
This compound is a synthetic small molecule with the chemical formula C22H23Cl2N5O2S and a molecular weight of approximately 492.42 Da[1][4][6]. It is classified as an alpha amino acid derivative, but there is no evidence of clinical use, approved indications, or ongoing clinical trials[1][4][7]. The compound has been referenced in structural biology databases (e.g., as ligand "5CB" in the Protein Data Bank), suggesting it may have been used for research purposes such as protein-ligand binding studies[8]. No information on its mechanism of action, pharmacological activity, or therapeutic application is available from current sources.
- Other names
- N-(5-chloro-benzo[b]thiophen-3-methyl)-2-[6-chlorooxo 3-(2-pyridin 2 yl ethylamino) 2h pyrazin 1 yl] acetamideCNP0569900.0CNP-0569900.0CNP 0569900.0CNP0569900.1CNP-0569900.1CNP 0569900.1
Beyond the preview
Go deeper on N-(5-chloro-benzo[b]thiophen-3-ylmethyl)-2-[6-chloro-oxo-3-(2-pyridin-2-yl-ethylamino)-2H-pyrazin-1-yl]-acetamide.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on N-(5-chloro-benzo[b]thiophen-3-ylmethyl)-2-[6-chloro-oxo-3-(2-pyridin-2-yl-ethylamino)-2H-pyrazin-1-yl]-acetamide.